NCT04868214View on ClinicalTrials.gov

Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

October 30, 2024

Conditions
Coagulation
Interventions
DEVICE

coagulation measurements

peak and trough coagulation measurements of patients treated with Xarelto, Eliquis, or Lixiana and coagulation measurements of healthy proband blood spiked with eiter Xarelto, Eliquis or Lixiana.

Trial Locations (5)

10605

RECRUITING

Perosphere Technologies Inc., White Plains

20850

RECRUITING

Perosphere Technologies Inc., Rockville

33437

RECRUITING

Perosphere Technologies Inc., Boynton Beach

55128

RECRUITING

Pfuetzner Science and Health Institute GmbH, Mainz

06811

RECRUITING

Perosphere Technologies Inc., Danbury

Sponsors
All Listed Sponsors
collaborator

Perosphere Technologies Inc.

INDUSTRY

lead

Sciema UG

OTHER

NCT04868214 - Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer | Biotech Hunter | Biotech Hunter